How should I interpret an echocardiogram that shows mildly reduced left ventricular ejection fraction (45‑50%) with anterior and apical hypokinesis, normal right ventricular function, no patent foramen ovale, mild aortic valve calcification and regurgitation, calcified mitral annulus, normal inferior vena cava collapse, and no pericardial effusion, and what are the recommended next steps in management?

Echocardiogram Interpretation: Mildly Reduced LVEF with Anterior/Apical Hypokinesis

This echocardiogram reveals a pattern highly suggestive of coronary artery disease affecting the left anterior descending (LAD) territory, requiring immediate stress testing or coronary angiography to assess for ischemia and guide revascularization decisions. 1

Critical Findings Requiring Action

1. Regional Wall Motion Abnormalities Point to LAD Disease

• The hypokinetic segments (entire anterior wall, entire anteroseptum, apical cap, apical lateral wall, and apical septum) follow a classic LAD distribution, strongly suggesting prior myocardial infarction or ongoing ischemia in this territory 1
• This pattern of regional wall motion abnormality (RWMA) in a patient with mildly reduced EF (45-50%) is not a benign finding and mandates evaluation for coronary artery disease 1
• The presence of segmental wall motion abnormalities distinguishes this from global cardiomyopathy and points toward an ischemic etiology 1

2. Ejection Fraction Classification and Implications

• An LVEF of 45-50% places this patient in the "mildly reduced" category (HFmrEF), which carries significant prognostic implications and triggers specific management pathways 2, 3
• This EF range is not benign—patients with LVEF 50-55% have a 3.64-fold increased risk of developing heart failure compared to those with LVEF ≥55%, and this risk increases further as EF drops below 50% 4
• The threshold of 55% is clinically important: patients with LVEF ≤55% have a 435-fold increased odds of progression to more severe LV dysfunction, particularly when ischemic etiology is present 5

Immediate Next Steps

Priority 1: Assess for Ischemia and Viability

• Stress echocardiography should be performed immediately to evaluate for residual ischemia post-PTCA (if applicable), assess contractile reserve and viability of the hypokinetic segments, and determine if additional revascularization would be beneficial 1
• If stress testing reveals significant inducible ischemia or if the patient has recurrent angina symptoms despite medical therapy, coronary angiography is warranted 1
• The goal is to identify potentially reversible ischemia that could improve with revascularization, as recovery of LV function may occur with optimal therapy 1

Priority 2: Initiate Guideline-Directed Medical Therapy

• Start foundational heart failure therapy immediately with a beta-blocker plus either an ACE inhibitor, ARB, or preferably an angiotensin receptor-neprilysin inhibitor (ARNI) 1, 2
• Add a mineralocorticoid receptor antagonist if symptoms persist after initiating foundational therapy 1, 2
• SGLT2 inhibitors (empagliflozin or dapagliflozin) should be initiated as they significantly reduce cardiovascular and all-cause mortality in patients with reduced EF, regardless of diabetes status 1, 2
• High-intensity statin therapy and antiplatelet therapy are mandatory for secondary prevention if coronary disease is confirmed 1

Priority 3: Aggressive Risk Factor Modification

• Lipid management with high-intensity statins, diabetes management, smoking cessation, blood pressure control (target <130/80 mmHg), and weight management are crucial 1
• These interventions can lead to normalization of mildly reduced EF in some cases 6

Additional Findings and Their Significance

Mild Aortic Valve Disease

• The mild aortic valve calcification and mild aortic regurgitation do not require intervention at this time 7
• Serial monitoring with echocardiography every 1-2 years is appropriate to assess for progression 7
• Aortic valve replacement would only be indicated if the patient develops symptoms, LVEF drops below 55% due to the valve disease specifically, or if undergoing other cardiac surgery 7

Mitral Annular Calcification

• The calcified mitral annulus is a degenerative finding associated with increased cardiovascular risk and can progress to cause mitral stenosis or regurgitation 8
• This finding is independently associated with increased all-cause mortality, atrial fibrillation, and stroke risk 8
• Monitor for development of symptomatic mitral valve dysfunction on follow-up echocardiograms 8

Normal Right Ventricular Function

• The normal RV systolic function (S' 11 cm/s) and normal IVC collapse pattern indicate preserved right heart function and normal right atrial pressure 1
• This is favorable prognostically and suggests the LV dysfunction has not yet caused significant pulmonary hypertension 1

Follow-Up Strategy

Short-Term (3-6 Months)

• Repeat echocardiography after 3 months of optimal medical therapy to assess for EF improvement and evaluate response to treatment 1
• If LVEF remains ≤35% despite 3 months of optimal medical therapy, evaluate for implantable cardioverter-defibrillator (ICD) placement 1
• Consider cardiac resynchronization therapy (CRT) if left bundle branch block develops or if the patient requires ventricular pacing 1

Long-Term Monitoring

• Serial echocardiography every 6-12 months to monitor for further EF decline, development of LV thrombus (given the apical hypokinesis), or progression of valvular disease 1
• Regular clinical follow-up to titrate medications to optimal doses, monitor for heart failure symptoms or recurrent angina, and assess for arrhythmias 1

Critical Pitfalls to Avoid

• Do not dismiss this as "mildly reduced" and defer action—the regional wall motion pattern demands evaluation for coronary disease 1
• Do not delay stress testing or angiography if there is any clinical suspicion of ongoing ischemia, as timely revascularization can improve outcomes 1
• Do not withhold guideline-directed medical therapy while awaiting further testing—initiate therapy immediately 2
• Do not use beta-blockers as monotherapy for the mild aortic regurgitation, as they can paradoxically worsen AR by reducing heart rate 7
• Consider anticoagulation if LV thrombus develops or if severe LV dysfunction occurs with atrial fibrillation 1